Skip to main content

Video Library

Videos
04/24/2025
Insights from an evidence-based educational program to prevent lung cancer caused by smoking and vaping were presented at the 2025 ONS Congress by Andria Caton, MSN, OCN, CHPN.
Insights from an evidence-based educational program to prevent lung cancer caused by smoking and vaping were presented at the 2025 ONS Congress by Andria Caton, MSN, OCN, CHPN.
Insights from an evidence-based...
04/24/2025
APP Institute Oncology
Youran Lee, MSN, BSN, RN
Videos
04/24/2025
Youran Lee, MSN, BSN, RN, discusses a study evaluating the different social and dietary factors, by symptom severity subgroup, of patients with colorectal cancer.
Youran Lee, MSN, BSN, RN, discusses a study evaluating the different social and dietary factors, by symptom severity subgroup, of patients with colorectal cancer.
Youran Lee, MSN, BSN, RN,...
04/24/2025
APP Institute Oncology
Grace Kyei, BSc, RN
Videos
04/24/2025
Grace Kyei, BSc, RN, discusses the results of an analysis of determinants of HPV vaccine uptake among males.
Grace Kyei, BSc, RN, discusses the results of an analysis of determinants of HPV vaccine uptake among males.
Grace Kyei, BSc, RN, discusses...
04/24/2025
APP Institute Oncology
Anne Mailhot, PA-C, University of Colorado Cancer Center
Videos
04/07/2025
Anne Mailhot, PA-C, presents the case of a patient with gastrointestinal stromal tumor with mutations in the KIT gene.
Anne Mailhot, PA-C, presents the case of a patient with gastrointestinal stromal tumor with mutations in the KIT gene.
Anne Mailhot, PA-C, presents the...
04/07/2025
APP Institute Oncology
Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP
Conference Coverage
11/27/2024
Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, assesses the effect implementing an academic-community partnership has on doctor of nursing students who are interested in oncology.
Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, assesses the effect implementing an academic-community partnership has on doctor of nursing students who are interested in oncology.
Christa Braun-Inglis, DNP, APRN,...
11/27/2024
APP Institute Oncology
Dylana Smith, MS, AGPCNP-BC, HNP
Conference Coverage
11/21/2024
Dylana Smith, MS, AGPCNP-BC, HNP, discusses an initiative to boost APP engagement at Memorial Sloan Kettering Cancer Center and the growth of the program since its inception.
Dylana Smith, MS, AGPCNP-BC, HNP, discusses an initiative to boost APP engagement at Memorial Sloan Kettering Cancer Center and the growth of the program since its inception.
Dylana Smith, MS, AGPCNP-BC,...
11/21/2024
APP Institute Oncology
Marlee Bogema, MSN, APRN, FNP-C
Conference Coverage
11/21/2024
Marlee Bogema, MSN, APRN, FNP-C, discusses a protocol developed by a community oncology practice which demonstrated that outpatient administration of bispecific antibodies is both safe and well-tolerated and reduces the number of required...
Marlee Bogema, MSN, APRN, FNP-C, discusses a protocol developed by a community oncology practice which demonstrated that outpatient administration of bispecific antibodies is both safe and well-tolerated and reduces the number of required...
Marlee Bogema, MSN, APRN, FNP-C,...
11/21/2024
APP Institute Oncology
Alrlene Siefker-Radke
Conference Coverage
11/15/2024
Arlene Siefker-Radtke, MD, provides an overview on the current treatment landscape for patients with advanced bladder cancer.
Arlene Siefker-Radtke, MD, provides an overview on the current treatment landscape for patients with advanced bladder cancer.
Arlene Siefker-Radtke, MD,...
11/15/2024
APP Institute Oncology
Benjamin Besse, MD, PhD
Videos
10/28/2024
Benjamin Besse, MD, PhD, discusses early analysis results from the MARIPOSA study which demonstrated that amivantamab plus lazertinib has promising antitumor activity in patients with advanced EGFR-mutated NSCLC.
Benjamin Besse, MD, PhD, discusses early analysis results from the MARIPOSA study which demonstrated that amivantamab plus lazertinib has promising antitumor activity in patients with advanced EGFR-mutated NSCLC.
Benjamin Besse, MD, PhD,...
10/28/2024
APP Institute Oncology
Beth Faiman, PhD, MSN
Videos
10/18/2024
Beth Faiman PhD, MSN, provides expert insight on tactics for managing oral toxicities associated with talquetamab treatment among patients with relapsed/refractory multiple myeloma.
Beth Faiman PhD, MSN, provides expert insight on tactics for managing oral toxicities associated with talquetamab treatment among patients with relapsed/refractory multiple myeloma.
Beth Faiman PhD, MSN, provides...
10/18/2024
APP Institute Oncology